Back to search
Familial Dysautonomia
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Familial Dysautonomia trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Familial Dysautonomia trials you may qualify forClinical diagnosis of Parkinson's disease (PD), multiple system atrophy (MSA) and dementia with Lewy bodies (DLB) is challenging, especially in the early stages…
Disorders of gut-brain interaction (DGBI) affect up to 25% of U.S. children. Patients often suffer from disabling, multisystem comorbidities that suggest a comm…
The study will collect clinical information from patients with FD and allow them to give blood to help develop biological markers of the disease to aid diagnosi…
The purpose of this study is to investigate whether speed-dependent measures of gait can be identified in patients with neurological conditions that affect gait…
CoRDS, or the Coordination of Rare Diseases at Sanford, is based at Sanford Research in Sioux Falls, South Dakota. It provides researchers with a centralized, i…
Human fibroblasts and possibly other human somatic cells may be reprogrammed into induced pluripotent stem (iPS) cells by the forced expression of transcription…
The purpose of this placebo controlled interventional study is to collect preliminary data on administering dexmedetomidine in patients with Familial Dysautonom…
The purpose of this study is to learn more about the effectiveness of palliative care training for community physicians and telemedicine support services for pa…